Skip to content
SEKISUI XenoTech DD Blog Logo

Author: Scott Hickman

In Vivo ADME Expertise Providing Cost Savings

ADME studies are a vital part of the drug development process, and therefore, deciding where and how to perform these studies...

To GLP or not to GLP?

That is the question. . . Knowing the answer may save you time and money Good Laboratory Practices (GLP) are...

Cypex Expands Portfolio of Recombinant Enzymes

As the exclusive distributor for Cypex in the US and Canada, SEKISUI XenoTech is proud to offer this portfolio of products based...

IQ Induction Working Group Publishes Recommendations for Data Interpretation of In Vitro Induction – Focus on CYP3A4 mRNA

SEKISUI XenoTech is proud to have made contributions to the paper entitled, “Considerations from the IQ Induction Working Group in...

New Guidance on Bioanalytical Services

SEKISUI XenoTech offers bioanalytical services to support both internal groups and external clients. We have validated LC-MS/MS methods for human CYP markers,...

Improve the Value of Your Molecule's Testing with Expert Insight

Our expert team of DDI and drug metabolism consultants can help you piece together the data for a successful data package that meets regulatory expectations for thorough risk assessment of a new or repurposed compound

Read our Follow-Up Interview in Outsourcing Pharma

Find the Q&A between Director of Scientific Consulting, Dr. Maciej Czerwinski, and the editorial team at Outsourcing Pharma for more answers about how DDI testing and data interpretation adds value to the drug repurposing process

Human antibodies, including monoclonal and polyclonal, are used for inhibition and immunoblot applications